Results 41 to 49 of about 570 (49)

Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

Lancet, The, 2019
Gholamreza Roshandel, Masoud Khoshnia, Hossein Poustchi   +2 more
exaly  

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

Lancet, The, 1998
Ludwig Kappos
exaly  

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

Lancet, The, 2004
Franz Fazekas, Carlo Pozzilli
exaly  

Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism

Lancet, The, 1999
Elif Hindié, Christian Jeanguillaume
exaly  

Medical marijuana for cancer

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations*

Lancet, The, 1999
Graeme J Hankey
exaly  

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

Lancet, The, 2009
exaly  

Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease

Lancet, The, 1994
exaly  

Microbial secondary metabolites: advancements to accelerate discovery towards application

Nature Reviews Microbiology
Hiroshi Otani, Drew T Doering, Jaime Lorenzo N Dinglasan   +2 more
exaly